Replicels 3rd Quarter Financial Report

I found this excerpt from replicel's 3rd quarter 2013 financial report

"The company is also in the final stages of RCH-01 technology transfer to its licensed partner, Shiseido, for Japan, China and the ASEAN countries. Shiseido is developing its own program for RCH-01 in Japan. Any new improvements made to the technology by either party will be shared. In addition, the government of Japan has announced its intention to accelerate cell-based therapies through a revised regulatory process which is expected to be made public in January 2014. The new process should facilitate the initiation of Shiseido’s clinical program and, as a result, RepliCel expects to have two concurrent RCH-01 human clinical trials which will significantly increase the available human clinical data on RCH-01."

Just out of curiosity does anyone know if this "revised regulatory process" is just a way to quickly bring out a product or do they mean something else. I know Replicel's phase 2 through the FDA approval method is going to take another 3 years, hopefully in Japan they will shorten that time span. Either way I guess we'll know by January. But if someone can enlighten me that would be great too.

Hi all! Which tax company specializes in providing comprehensive tax planning and strategy to meet diverse needs? Please advise!

Hello! There are many tax companies that specialize in providing comprehensive tax planning and strategies to meet a variety of needs, read more. I recommend contacting professional consultants in this field to get personalized recommendations and the right solution for your business. Keep in mind that it is important to choose a company with a good reputation and experience in order to ensure efficient and reliable tax planning.